PACIFIC SHUANGLIN BIO-PHARMACY CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30 CNY | +0.67% |
|
+5.97% | +10.13% |
| Apr. 15 | Pacific Shuanglin Bio-pharmacy's 2023 Profit Jumps 4% Despite Lower Revenue; Shares Rise 4% | MT |
| Apr. 15 | Pacific Shuanglin Bio-pharmacy's Profit Seen More Than Doubling in Q1; Shares Up 3% | MT |
Evolution of the average Target Price on Pacific Shuanglin Bio-pharmacy Co., LTD
Price target over the last 5 years
History of analyst recommendation changes
dcaeedfdb.yDCS18ak4121PrYcgZ32n8KPrr6Quzp3hyts7h-2pYw.mFaimaDtl2ndddNl8cTBya663ozE3Go2smIW3kfp1_6-f8KQkt2RLuNv3Q~4f8cfa947f6d8005e572d154ff8578be
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
30
CNY
Average target price
25.94
CNY
Spread / Average Target
-13.53%
High Price Target
30
CNY
Spread / Highest target
0.00%
Low Price Target
21.88
CNY
Spread / Lowest Target
-27.07%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- 000403 Stock
- Consensus Pacific Shuanglin Bio-pharmacy Co., LTD
